On Friday, Rapid Micro Biosystems Inc (NASDAQ: RPID) opened lower -12.30% from the last session, before settling in for the closing price of $3.66. Price fluctuations for RPID have ranged from $0.58 to $4.04 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 11.76% over the past five years. Company’s average yearly earnings per share was noted 11.20% at the time writing. With a float of $20.43 million, this company’s outstanding shares have now reached $37.72 million.
Let’s look at the performance matrix of the company that is accounted for 193 employees. In terms of profitability, gross margin is -4.82%, operating margin of -198.23%, and the pretax margin is -184.78%.
Rapid Micro Biosystems Inc (RPID) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Rapid Micro Biosystems Inc is 52.52%, while institutional ownership is 15.94%. The most recent insider transaction that took place on Dec 03 ’24, was worth 10,880. In this transaction Director of this company bought 10,880 shares at a rate of $1.00, taking the stock ownership to the 45,180 shares. Before that another transaction happened on Dec 05 ’24, when Company’s Director bought 9,120 for $1.04, making the entire transaction worth $9,484. This insider now owns 54,300 shares in total.
Rapid Micro Biosystems Inc (RPID) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.40% during the next five years compared to -16.10% drop over the previous five years of trading.
Rapid Micro Biosystems Inc (NASDAQ: RPID) Trading Performance Indicators
Check out the current performance indicators for Rapid Micro Biosystems Inc (RPID). In the past quarter, the stock posted a quick ratio of 4.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.11, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.92 in one year’s time.
Technical Analysis of Rapid Micro Biosystems Inc (RPID)
Rapid Micro Biosystems Inc (NASDAQ: RPID) saw its 5-day average volume 0.6 million, a positive change from its year-to-date volume of 0.42 million. As of the previous 9 days, the stock’s Stochastic %D was 73.13%. Additionally, its Average True Range was 0.41.
During the past 100 days, Rapid Micro Biosystems Inc’s (RPID) raw stochastic average was set at 74.04%, which indicates a significant increase from 64.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 180.20% in the past 14 days, which was higher than the 103.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.71, while its 200-day Moving Average is $1.07. Nevertheless, the first resistance level for the watch stands at $3.63 in the near term. At $4.05, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.36. If the price goes on to break the first support level at $2.90, it is likely to go to the next support level at $2.59. The third support level lies at $2.18 if the price breaches the second support level.
Rapid Micro Biosystems Inc (NASDAQ: RPID) Key Stats
There are currently 43,034K shares outstanding in the company with a market cap of 138.14 million. Presently, the company’s annual sales total 22,520 K according to its annual income of -52,470 K. Last quarter, the company’s sales amounted to 7,600 K and its income totaled -11,320 K.
